Duncan Macewan Person All right, so shifting gears over to demand
Zyoud SH, Shakhshir M, Abushanab AS et al (2023) Gut microbiota and autism spectrum disorders: where do we stand
Quarato et al., 2022) (Figure 3)
The door shelf is convenient
As the SELECT trial nears completion, a similar large trial was launched in autumn 2022, but this one involves a new wrinkle on GLP-1 receptor agonism that appears to yield even greater weight loss
Researchers choose BPC-157 for its uniquely broad profile: it accelerates tissue repair , drives new blood-vessel formation , and protects gastrointestinal lining , all within a single peptide